Letters, Testimony & Comments

The Honorable Patrick Leahy Chairman Committee on the Judiciary United States Senate Washington, D.C. 20510...
April 2 2014
BIO commends the Brazilian Government for its efforts to revisit its policies with the goal of developing a legal framework that...
November 20 2013
BIO appreciates this fourth opportunity to formally respond to the Colombian Ministry of Health’s Draft Decree on Regulatory...
October 16 2013
Therapeutic biologics are an opportunity to address unmet patient needs, drive innovation, and assist China's transformation into a...
July 10 2013
Biologics are complex medicines that are manufactured using living organisms.  Due to their size and complexity, biologics are...
July 8 2013
A concerted effort through the TTIP to unleash the potential of biotechnology in the Transatlantic economy and beyond will go a long way...
June 19 2013
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations...
June 19 2013
BIO commends the Government of Peru for its endeavor to create a pathway for the approval of biological and biotechnological products....
March 21 2013
BIO commends the government of Colombia for taking steps towards developing regulatory requirements for the registry of medicines of...
February 22 2013
Biotechnology companies provide unique benefits to the United States and the world. In the health care sector alone, the industry has...
February 8 2013
BIO respectfully submits both questions and comments for the National Health Surveillance Agency’s (ANVISA) consideration on the...
February 1 2013
Given the importance of protections for basic biotechnology inventions to the survival of the biotechnology sector in India, BIO has...
January 18 2013
The Biotechnology Industry Organization (BIO) is grateful for the opportunity to provide comments on India’s Draft National IPR...
November 8 2012
BIO supports the President’s decision to include Mexico in the TPP trade negotiations. Providing effective intellectual property...
September 5 2012
I. Agricultural and Animal Biotechnology The Government of Canada has long been a trusted ally to the United States on agricultural...
September 4 2012
The Biotechnology Industry Organization (BIO) appreciates the U.S. Trade Representative's (USTR) query about BIO's views on how...
August 17 2012
The United States Patent and Trademark Office (USPTO) has led the world in providing technical expertise and training to various patent...
July 26 2012
The U.S. Intellectual Property Rights Attaché Program has had significant success and holds immense promise in helping to enhance...
June 28 2012
  The House Judiciary Committee conducted a hearing on World IP Day on "International Patent Issues: Promoting...
April 26 2012
BIO has identified the following countries of interest and recommends the following for our 2011 Special 301 submission. Priority...
February 14 2012
By Electronic Submission To the State Intellectual Property Office, The Biotechnology Industry Organization (BIO) appreciates this...
December 9 2011
By Electronic Submission Ip.policy@uspto.gov Office of Policy and External Affairs United States Patent and Trademark Office...
November 10 2011
By electronic submission Saurabh Vishnubhakat Attorney Advisor, Office of Chief Economist United States Patent and Trademark...
October 27 2011
By electronic submission   Mr. Stan McCoy Assistant USTR for Intellectual Property and Innovation Office of the U.S. Trade...
October 20 2011
Dear Secretary Locke: On behalf of the Biotechnology Industry Organization (BIO) and the Pharmaceutical Research and Manufacturers of...
May 13 2011
Re: Request for Comments on the Strategy for American Innovation Subject: Innovation Strategy RFI Email: competitiveness@doc.gov Dear...
April 1 2011
The Biotechnology Industry Organization (BIO) appreciates the opportunity to participate in the Special 301 process and is hopeful that...
February 15 2011
RE: Participation of Malaysia in the Trans-Pacific Partnership Trade Negotiations Dear Ms. Blue: The Biotechnology Industry...
November 22 2010
October 14, 2010 To: Members of the Ad Hoc Open-ended Working Group on Access and Benefit-sharing of the Convention on Biological...
October 14 2010
The Biotechnology Industry Organization (BIO) appreciates the opportunity to provide comments on India’s Department of Industrial...
September 29 2010
Biotechnology companies would be less likely to export their products into countries that do not provide meaningful IP and data...
July 26 2010
Intellectual Property Innovation and Chair of the Special 301 Committee Office of the United States Trade Representative Washington, D...
February 18 2010
Dear Ms. Blue: The Biotechnology Industry Organization (BIO) is submitting this letter in response to the request by the United States...
November 1 2009
  VIEWS AND PROPOSALS OF THE BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO) AND THE PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF...
July 31 2009
U.S. Department of State
June 1 2009
Office of the U.S. Trade Representative
March 11 2009
Office of the U.S. Trade Representative
February 19 2009
Re: Sugestões ao projeto de lei que dispõe sobre o access tos recursos genéticos e seus derivados Dear Sir/Madam...
February 28 2008
Re: Special 301: Identification of Countries Under Section 182 of the Trade Act of 1974: Request for Public Comment, 73 Fed. Reg. 2958 (...
February 11 2008
Office of the U.S. Trade Representative
February 11 2008
BIO commends the IGWG for its work on a global strategy and plan of action that, according to its mandate, will aim at "securing an...
January 1 2008
The Biotechnology Industry Organization (BIO) appreciates the opportunity to provide comments on the U.S. Council for International...
August 16 2007
Office of the U.S. Trade Representative
March 8 2007
RE: Identification of Countries Under Section 182 of the Trade Act of 1974: Request for Public Comment, 72 Reg. 1033 (January 9, 2007)...
February 1 2007
To: Members of the TRIPS Council, World Trade Organization From: The Presidents of the Biotechnology Industry Organization, BIOTECanada...
October 23 2006
Office of the U.S. Trade Representative
September 18 2006
To the State Intellectual Property Office of the People's Republic of China
August 28 2006
Dear Ambassador Schwab: The Russian Federation's accession to the World Trade Organization (WTO) would be an important step forward...
June 9 2006
Letter to USTR on continuing concerns.
March 31 2006
Comments to the USTR touching on Intellectual Property Rights, Biosafety Protocol Implementation, Adventitious Presence, and Labeling.
March 24 2006
February 13 2004
Identifying countries of concern as per the Trade Act of 1974
February 14 2003
Letter to The Honorable Robert Zoellick, US Trade Representative
January 29 2003
Letter to The Honorable Robert Zoellick, US Trade Representative
November 27 2002
RE: Notice of Public Hearing Concerning China's Compliance with WTO Commitments Written Comments (Federal Register Vol. 71, No. 145...
Every Year... -of the 57 million people who die, 10.5 million are children under 5 years and 1.5 million are children between the ages...
Government's role in developing solutions for diseases that disproportionately affect developing countries Introduction: -...
National Institutes of Health: An International Perspective NIH Mission: To uncover new knowledge that will lead to improved public...
Innovation And The Global Research Enterprise WORLD HEALTH ORGANIZATION GENEVA—NOVEMBER 2007 THEODORE J. ROUMEL VICE PRESIDENT...
July 14 2014
Dear Chairman Terry and Ranking Member Schakowsky: On behalf of the Biotechnology Industry Organization (BIO), I write in support of H.R. ___, the Targeting Rogue and Opaque Letters (TROL) Act of 2014, and urge the Subcommittee to pass this legislation. It is critical that legislation that seeks to reign in abuses by patent trolls does so in a way that preserves and enhances the incentives necessary to sustain our nation’s global leadership in biotechnology innovation and to spur the creation of high-wage, high-value jobs throughout the country. Improving our patent system can help America retain its global competitive advantage in biotechnology and other innovative industries, and will spur more investment and job creation at a time when both are sorely needed. We commend Chairman Terry and Members of the Subcommittee on Commerce, Manufacturing, and Trade for creating a balanced approach that will address the issue of false or deceptive patent demand letters without impeding the ability of legitimate patent owners to enforce their patents by sending patent-related communications made in good faith.
April 2 2014
BIO joins coalition letter to Chairman Patrick Leahy and Ranking Member Chuck Grassley expressing serious concerns with the direction of patent legislation.
November 20 2013
BIO welcomes the opportunity to provide the views of its members on facilitating access to genetic resources and traditional knowledge and the sharing of benefits from their use...
October 16 2013
BIO appreciates this fourth opportunity to formally respond to the Colombian Ministry of Health’s Draft Decree on Regulatory Requirements for the Registry of Medicines of Biological Origin and we refer you to our previous comments filed to the Colombian Ministry of Health on April 24th 2012, June 12th 2012 and February 21st 2013 for background about BIO and its interest in this Decree. 
July 10 2013
Therapeutic biologics are an opportunity to address unmet patient needs, drive innovation, and assist China's transformation into a knowledge-intensive economy.
January 13 2014
BIO expresses strong support for the “Bipartisan Congressional Trade Priorities Act of 2014”, which was issued by a bipartisan group of leaders from the Senate Finance and House Ways and Means Committee last week. 
June 13 2013
The SCOTUS decision represents a departure from judicial and PTO precedent supporting patentability of DNA molecules. The decision could create business uncertainty for a range of inventions.
May 14 2013
BIO welcomes the unanimous Supreme Court decision in Bowman v. Monsanto, in which the Court confirms that biotechnology seed is entitled to the same protections as other inventions under the patent law.
February 21 2011
The Biotechnology Industry Organization (BIO) stresses the critical importance of protecting intellectual property abroad in comments recently filed with the U.S. Trade Representative (USTR) on the 2011 Special 301 Review.